Platelet Activation Determines Angiopoietin-1 and VEGF Levels in Malaria: Implications for Their Use as Biomarkers

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Brouwers, Judith ^a   Noviyanti, Rintis ^b   Fijnheer, Rob ^a   de Groot, Philip G ^a   Trianty, Leily ^b   Mudaliana, Siti ^b   Roest, Mark ^a   Syafruddin, Din ^b   van der Ven, Andre ^c   de Mast, Quirijn ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BIOLOGICAL MARKER; CHEMOKINE; CXCL7 CHEMOKINE; HEMOGLOBIN; PADGEM PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; ANGPT1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CELL ACTIVATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HUMAN; MALARIA; MALE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PROTEIN SECRETION; SCHOOL CHILD; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; BLOOD; CASE CONTROL STUDY; NONPARAMETRIC TEST; YOUNG ADULT;

PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; ANGIOPOIETIN-1; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALARIA; MALE; PLATELET ACTIVATION; PLATELET COUNT; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84878642213     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064850     Document Type: Article

References (31)

1. de Mast Q, Groot E, Lenting PJ, de Groot PG, McCall M, et al. (2007) Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. J Infect Dis 196: 622-628.
2. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, et al. (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276: 7614-7620.
3. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
4. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, et al. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463.
5. Thurston G, Rudge JS, Ioffe E, Papadopoulos N, Daly C, et al. (2005) The anti-inflammatory actions of angiopoietin-1. EXS 94: 233-245.
6. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, et al. (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-239.
7. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, et al. (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 3: e46.
8. Jain V, Lucchi NW, Wilson NO, Blackstock AJ, Nagpal AC, et al. (2011) Plasma levels of angiopoietin-1 and-2 predict cerebral malaria outcome in Central India. Malar J 10: 383.
9. Lovegrove FE, Tangpukdee N, Opoka RO, Lafferty EI, Rajwans N, et al. (2009) Serum angiopoietin-1 and-2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One 4: e4912.
10. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, et al. (2008) Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A 105: 17097-17102.
11. Conroy AL, Lafferty EI, Lovegrove FE, Krudsood S, Tangpukdee N, et al. (2009) Whole blood angiopoietin-1 and-2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J 8: 295.
12. Conroy AL, Phiri H, Hawkes M, Glover S, Mallewa M, et al. (2010) Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One 5: e15291.
13. Li JJ, Huang YQ, Basch R, Karpatkin S, (2001) Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost 85: 204-206.
14. Mohle R, Green D, Moore MA, Nachman RL, Rafii S, (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A 94: 663-668.
15. Nachman RL, Rafii S, (2008) Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 359: 1261-1270.
16. Kuhne T, Hornstein A, Semple J, Chang W, Blanchette V, et al. (1995) Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole. Am J Hematol 50: 40-45.
17. Zimmermann R, Koenig J, Zingsem J, Weisbach V, Strasser E, et al. (2005) Effect of specimen anticoagulation on the measurement of circulating platelet-derived growth factors. Clin Chem 51: 2365-2368.
18. van Bladel ER, Roest M, de Groot PG, Schutgens RE, (2011) Up-regulation of platelet activation in hemophilia A. Haematologica. 96: 888-895.
19. Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, et al. (1997) The origin of P-selectin as a circulating plasma protein. Thromb Haemost 77: 1081-1085.
20. de Mast Q, de Groot PG, van Heerde WL, Roestenberg M, van Velzen JF, et al. (2010) Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy. Br J Haematol 151: 495-503.
21. Casals-Pascual C, Idro R, Gicheru N, Gwer S, Kitsao B, et al. (2008) High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc Natl Acad Sci U S A 105: 2634-2639.
22. Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, et al. (2008) Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 7: 83.
23. Golanski J, Pietrucha T, Baj Z, Greger J, Watala C, (1996) Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. Thromb Res 83: 199-216.
24. Lei H, Gui L, Xiao R, (2009) The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma. Clin Biochem 42: 1452-1460.
25. Zimmermann R, Ringwald J, Eckstein R, (2009) EDTA plasma is unsuitable for in vivo determinations of platelet-derived angiogenic cytokines. J Immunol Methods 347: 91-92.
26. Ranieri G, Coviello M, Chiriatti A, Stea B, Montemurro S, et al. (2004) Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls. Oncol Rep 11: 435-439.
27. Starlinger P, Alidzanovic L, Schauer D, Brugger P, Sommerfeldt S, et al. (2011) Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts. Dis Markers 31: 55-65.
28. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, et al. (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77: 956-964.
29. Zimmermann R, Arnold D, Strasser E, Ringwald J, Schlegel A, et al. (2003) Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 85: 283-289.
30. Ho-Tin-Noe B, Demers M, Wagner DD, (2011) How platelets safeguard vascular integrity. J Thromb Haemost 9Suppl 1: 56-65.
31. Iannacone M, Sitia G, Isogawa M, Whitmire JK, Marchese P, et al. (2008) Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A 105: 629-634.